SCHEMBL11162328

SCHEMBL11162328

CC1CC(=O)NN=C1c1ccc(NC(=O)Sc2ccc(F)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 16/20 0.65
▸ PDE3A Q14432 15/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ MAPT P10636 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ TNNC1 P63316 1/20 0.51
▸ PDE4A P27815 2/20 0.45
▸ PDE4B Q07343 2/20 0.45
▸ PDE4C Q08493 2/20 0.45
▸ PDE4D Q08499 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11175176 0.90 PDE3B (0.66) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11163401 0.89 PDE3B (0.65) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11162969 0.89 PDE3B (0.67) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11171310 0.87 PDE3B (0.61) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11167091 0.86 PDE3B (0.60) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11172793 0.85 PDE3B (0.61) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11165047 0.84 PDE3B (0.77) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL10731125 0.84 PDE3B (0.69) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11159545 0.81 PDE3B (0.58) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL16156998 0.81 PDE3B (0.62) PDE3BPDE3AMAPTTNNC1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4415571-A HYPOTENSIVE AGENTS; THROMBOSIS; ANTICOAGULANTS; CARDIOVASCULAR DISORDDERS BASF AKTIENGESELLSCHAFT (DE) 1983-11-15 — — US disclosed
EP-0042513-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-30 — — EP disclosed
Send feedback